Trials / Sponsors / Bradmer Pharmaceuticals Inc.
Bradmer Pharmaceuticals Inc.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Neuradiab® Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma Multiforme Brain Tumors | Phase 2 | 2009-05-01 |
| Terminated | Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy Glioblastoma Multiforme | Phase 3 | 2008-06-01 |